Could a simple shoe insert ease chronic hip pain?
NCT ID NCT06891001
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding a neutral shoe insert to standard physical therapy helps people with long-term hip pain (greater trochanteric pain syndrome). About 36 adults with unilateral hip pain for over three months will be assigned to physical therapy plus a shoe insert on the affected side, a sham insert on both sides, or physical therapy alone. Researchers will measure pain, function, and movement at 12 weeks and 6 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- neutral shoe insert
- What this could lead to
- If it works, this could point toward a simple, low-cost addition to physical therapy for reducing hip pain and improving movement.
- What could go wrong
- This is a small, early-stage trial with only 36 participants, so results may not apply widely. The shoe insert may provide no extra benefit over physical therapy alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 36 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Jan 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subjects with a history of unilateral hip pain lasting more than three months. * Subjects with a VAS pain score of at least 3/10 localized to the lateral hip. * Subjects with pain with palpation to lateral hip. * Subjects with pain with either resisted hip abduction in relative adduction testing position and/or single leg stance test Exclusion Criteria: * Subjects wearing custom foot orthoses at the time of recruitment. * Subjects who endorse current low back pain ≥ 3 on the NRS or lumbar radiculopathy * Subjects with a medical history of spinal or lower limb surgery in the past 6 months. * Subjects with a medical history of total joint replacement of hip, knee, or ankle on the symptomatic side * Subjects who have had a corticosteroid injection at the hip within the last 12 months; * Subjects demonstrating clinical signs and symptoms of intra-articular hip joint pathology with ≥ 3/10 groin pain including imaging confirmed significant labral tearing requiring surgery or osteoarthritis \> 2 (mild) on Kellgren-Lawrence score on radiographs. * Subjects previously diagnosed with systemic inflammatory conditions; active cancer/malignant tumors; or neurological conditions that would affect gait * Subjects who have had physical therapy within the past 3 months for hip pain * If subjects are unable to commit to 12 weeks of therapy with one supervised session weekly * Subjects who have the intention to perform treatments outside of this study including, but not limited to, dry needling or acupuncture, extracorporeal shockwave, therapeutic ultrasound, a TENEX procedure, medication injection therapies, platelet-rich plasma injections, stem cell injections, and surgery.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gluteus medius muscle strength are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mayo Clinic
Glendale, Arizona, 85031, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.